Related Experiment Video
Updated: Sep 30, 2025

Myocardial Infarction and Functional Outcome Assessment in Pigs
Published on: April 25, 2014
Coronary Artery Ectasia in the Pathophysiology of Myocardial Infarction With Nonobstructive Coronary Arteries
Mehmet Eyuboglu1, Canan Eyuboglu2
1Department of Cardiology.
Insights
Coronary artery ectasia (CAE) is linked to myocardial infarction with nonobstructive coronary arteries (MINOCA). This study found CAE is more common in MINOCA patients, suggesting it
Area of Science:
- Cardiology
- Vascular Biology
Background:
- Coronary artery ectasia (CAE) is associated with increased risk of acute myocardial infarction (AMI).
- Myocardial infarction with nonobstructive coronary arteries (MINOCA) mechanisms remain unclear.
- The role of CAE in MINOCA pathogenesis requires investigation.
Purpose of the Study:
- To investigate the association between coronary artery ectasia (CAE) and myocardial infarction with nonobstructive coronary arteries (MINOCA).
Main Methods:
- A cohort of 1,284 patients with non-ST-segment elevation myocardial infarction was analyzed.
- Patients were categorized into MINOCA (no obstructive CAD) and non-MINOCA (obstructive CAD) groups.
- The frequency of CAE was compared between groups, and its association with MINOCA was assessed.
Main Results:
- MINOCA was diagnosed in 7.9% of patients; obstructive CAD in 92.1%.
- CAE prevalence was significantly higher in the MINOCA group (22.8%) compared to the obstructive CAD group (3.5%).
- CAE independently predicted MINOCA in patients with non-ST-segment elevation myocardial infarction (OR 1.812).
Conclusions:
- Coronary artery ectasia may be a risk factor for MINOCA.
- CAE could play a role in the pathophysiology of MINOCA.
- Further research into CAE as a contributor to MINOCA is warranted.
Abstract:
Coronary artery ectasia (CAE) is associated with an increased risk for acute myocardial infarction (AMI). A significant proportion of patients with AMI have no obstructive coronary artery disease (CAD), however, the underlying mechanism of myocardial infarction with nonobstructive coronary arteries (MINOCA) is poorly understood. Therefore, the present study aimed to investigate whether CAE has a role in the pathogenesis of MINOCA. A total of 1,284 patients who were admitted with a diagnosis of non-ST-segment elevation myocardial infarction were included in the study. Patients were divided into 2 groups according to the presence or absence of obstructive CAD (≥50% stenosis). Patients without obstructive CAD (MINOCA group) and patients with obstructive CAD (no-MINOCA group) were compared regarding the frequency of CAE. Additionally, the association between CAE and MINOCA was investigated. In the study participants, 101 patients (7.9%) were diagnosed with MINOCA, whereas 1,183 (92.1%) had AMI with obstructive CAD. Importantly, the frequency of patients with CAE was significantly higher in patients with MINOCA compared with those with obstructive CAD (22.8% vs 3.5%, p <0.001). Moreover, CAE was observed in 64 patients (4.9%). The frequency of MINOCA was found to be significantly higher in patients with CAE compared with patients without CAE (35.9% vs 6.4%, p <0.001). Furthermore, multivariate analysis demonstrated that the presence of CAE was an independent predictor of MINOCA in patients presented with a diagnosis of non-ST-segment elevation myocardial infarction (odds ratio 1.812, 95% confidence interval 1.376 to 2.581, p <0.001). In conclusion, CAE may be considered as a risk factor for MINOCA and may have a role in the pathophysiology of MINOCA.
More Related Videos
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Coronary Artery Disease I: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Coronary Artery Disease III: Clinical Manifestations

